Scientists in Pennsylvania have developed an experimental mRNA-based vaccine for C. diff bacteria, which often cause ...

However, Novavax's shares recently dropped by about 20% in one day after it announced a clinical setback. The biotech's stock ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Flu viruses typically spread in fall and winter, with activity peaking between December and February. Getting vaccinated in the fall can lower your chances of getting the flu (influenza). Flu is a ...

The FDA has approved updated labeling for Flublok (influenza vaccine) to include new safety data involving pregnant individuals.

NPR reports that the FDA is not including one of the strains of flu — B/Yamagata — in this year's recipe because covid prevention initiatives appear to have pushed it into oblivion. Meanwhile, ...

A summary of recent health news updates reveals declining Marburg cases in Rwanda, Texas suing a doctor over prescribing ...

Recent health developments include Rwanda's declining Marburg cases amidst rising mpox, legal actions in Texas against ...

Novavax announced Wednesday that the Food and Drug Administration (FDA) has placed a clinical hold on its application for a ...

The report involved motor neuropathy in a participant of the phase 2 trial conducted outside the U.S., according to an Oct. 16 news release from the company. The participant received the vaccine in ...

Folks who want solid protection during the cold and flu season should get the influenza vaccine now, the U.S. Food and Drug ...

Analyst Eric Joseph of J.P. Morgan maintained a Sell rating on Novavax (NVAX – Research Report), retaining the price target of $9.00.